Use of Artificial Intelligence (AI) and Machine Learning Applications in Microbiology
Main Article Content
Abstract
Background: Artificial Intelligence (AI) and Machine Learning (ML) are rapidly transforming the field of microbiology by improving the accuracy, speed, and efficiency of disease diagnosis, microbial identification, antimicrobial susceptibility testing, and outbreak surveillance. These advanced technologies facilitate the analysis of large microbiological data sets and support clinical decision- making, thereby enhancing patient care and public health outcomes.
Objective: To review the applications, advantages, and future prospects of AI and Machine Learning in microbiology and their role in improving diagnostic and research capabilities.
Methods: A comprehensive review of published literature was conducted using scientific databases, including PubMed, Google Scholar, and Scopus. Relevant articles focusing on AI and ML applications in clinical microbiology, diagnostic microbiology, antimicrobial resistance detection, epidemiological surveillance, and laboratory automation were analyzed.
Results: AI and ML have demonstrated significant potential in various microbiological applications. These technologies enable rapid identification of microorganisms through image analysis, automated interpretation of culture plates, molecular diagnostics, genomic data analysis, and prediction of antimicrobial resistance patterns. AI-based systems have improved the detection of infectious diseases such as tuberculosis, COVID-19, sepsis, and bloodstream infections. Furthermore, machine learning algorithms facilitate outbreak prediction, disease surveillance, and personalized treatment strategies. The integration of AI with laboratory information systems has also enhanced workflow efficiency and reduced human errors.
Conclusion: Artificial Intelligence (AI) and Machine Learning (ML) are transforming modern microbiology by enabling rapid, precise, and cost-effective diagnostic approaches. These technologies play a significant role in microbial identification, prediction of antimicrobial resistance, disease surveillance, and outbreak detection. Their integration into microbiological practices has the potential to enhance healthcare services, support clinical decision-making, and improve patient outcomes. With ongoing technological advancements, proper validation, and adherence to ethical standards, AI and ML are expected to have an increasingly important role in both clinical and research microbiology in the future.
Article Details
Section
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
How to Cite
References
References
1.Mondal,R.S.,Akter,L.,Bhuiyan,M.N.A.(2025)."Integrating AI and ML techniques in modern microbiology", Applied IT & Engineering, 3(1),1-10,10323
2.Jiang,Y.,Luo,J.,Huang,D.,Liu,Y.,&Li,D.D.(2022).Machine learning advances in microbiology: A review of methods and applications. Frontiers in Microbiology, 13, 925454.
3.Mintz,Y.,&Brodie,R.(2019).Introduction to artificial intelligence in medicine.Minimally Invasive Therapy & Allied Technologies, 28(2), 73-81.
4.Kaul,V.,Enslin,S.,&Gross,S. A.(2020).History of artificial intelligence in medicine.Gastrointestinal endoscopy, 92(4), 807-812.
5.JordanM.I.,Mitchell T.M.(2015).Machine learning:trends, perspectives,and prospects.Science349,255– 260.
6.Domingos P.(2012).A few useful things to know about machin learning.Commun.ACM55,78–87.
7.Becht,E., McInnes, L.,Healy,J.,Dutertre,C.A.,Kwok,I.W.H.,Ng,L.G.,etal.(2018).Dimensionality reduction for visualizing single-cell data usingUMAP. Nat. Biotechnol. 37, 38–44. doi:10.1038/nbt.4314
8.Cammarota,G.,Ianiro,G.,Ahern, A.,Carbone,C.,Temko, A.,Claesson,M.J.,etal.(2020).Gut microbiome, big data,and machine learning to promote precision medicine for cancer.Nat.Rev.Gastroenterol.Hepatol.17, 635–648. doi: 10.1038/s41575-020-0327-3
9.Campbell, T. W., Wilson, M. P., Roder, H., MaWhinney, S., Georgantas, R. W., 3rd, Maguire, L. K., et al. (2021).Predicting prognosis in COVID-19 patients using machine learning and readily available clinical data. Int. J. Med. Inform. 155, 104594.
10.Cao, J., Xiao, Y., Zhang, M., Huang, L., Wang, Y., Liu, W., et al. (2023). Deep learning of dual plasma fingerprintsfor high-performanceinfectionclassification.Small19,e2206349.doi:10.1002/smll.202206349
11.Chen,X.,Ren,B.,Chen,M.,Wang,Q.,Zhang, L.,Yan,G.(2016).NLLSS:Predicting synergistic drug combinations based on semi-supervised learning. PloS Comput. Biol. 12, e1004975. Doi: 10.1371/journal.pcbi.1004975
12.David,J.A.,Zhichao, A.,Mark,A.,Chris,A.,Allcock, A.,Brian,A.,etal.(2022).A blood atlas of COVID-19 defines hallmarks of disease severity and specificity. Cell 185, 916– 938.e58.
13.DeFátima Cobre, A.,Surek,M.,Stremel,D.P.,Fachi,M. M.,LoboBorba,H.H.,Tonin,F.S., etal.(2022). Diagnosis and prognosis of COVID-19 employing analysis of patients’ plasma and serum via LC-MS and machine learning. Comput. Biol. Med.. 146, 105659.
14.Deo,R.C.(2015).Machine learning in medicine.Circulation132,1920–1930.doi: 10.1161/CIRCULATIONAHA.115.001593
15.Fabian,P.,Gaël,V.,Alexandre,G.,Vincent,M.,Bertrand,T.,Olivier,G.,etal.(2011).Scikitlearn:Machine Learning in Python. J. Mach. Learn. Res. 12, 2825–2830.
16.Gao,A.,Kouznetsova,V. L.,Tsigelny, I.F.(2022).Machine-learning-based virtual screening to repurpose drugs for the treatment of Candida albicans infection. Mycoses 65, 794–805. doi: 10.1111/myc.13475
17.Habgood-Coote, D., Wilson, C., Shimizu, C., Barendregt, A. M., Philipsen, R., Galassini, R., et al. (2023). Diagnosis of Childhood FebrileIllness Usinga Multiclass Blood RNA Molecular Signature.Med4,635–654.e5. doi: 10.1016/j.medj.2023.06.007
18.Kaufman,S.,Rosset, S.,Perlich,C., Stitelman,O.(2012).Leakageindata mining:Formulation, detection,and avoidance. ACM Trans. Knowl. Discovery Data 6, 1– 21. doi: 10.1145/2382577.2382579
19.Kaul,V.,Enslin,S.,Gross,S. A.(2020).History of artificial intelligence in medicine.Gastrointes tEndosc92, 807–812. doi: 10.1016/j.gie.2020.06.040
20.Shan,W.,Li,X.,Yao,H.,Lin,K.(2021).Convolutional neuralnetwork-basedvirtualscreening.Curr.Med. Chem. 28, 2033–2047. doi: 10.2174/0929867327666200526142958
21.Siddique,M.A.B.,Debnath,A.,Nath,N.D.,Biswash,M.A.R.,Tufael(2018)."Advancing Medical Science through Nanobiotechnology: Prospects, Applications, and Future Directions", Journal of Primeasia,
1.1(1),1-7,10163